Abstract:Abstract Background Pelvic lymph node metastasis (LNM) is a crucial independent prognostic factor in cervical cancer (CCa) and serves as an indicator for radiation therapy as the primary or an adjuvant treatment option. However, preoperative diagnosis of LNM remains challenging. Thus, we aimed to identify biomarkers of LNM in patients with presumed early-stage CCa. Methods The differentially expressed genes (DEGs) between tumours with different lymph node statuses were identified by using The Cancer Genome Atlas database. Then, univariate Cox regression analysis and Kaplan–Meier analyses were utilized to screen overall survival (OS)-associated genes. Multivariate Cox analysis and logistical analysis were utilized to evaluate independent risk factors for OS and LNM, respectively. Subsequently, the protein level of fatty acid binding protein 4 (FABP4) was detected in normal cervical and CCa tissues by immunohistochemistry assays. EdU assays were performed to determine whether FABP4 altered the proliferation of cervical cancer cells. Wound healing and Transwell assays were conducted to explore the effects of FABP4 depletion on migratory and invasive abilities of cervical cancer cells. F-actin fluorescence staining were performed to investigate morphological change and Western blotting analyses were performed to determine epithelial mesenchymal transition-related marker expression and downstream signalling pathways. Results A total of 243 DEGs, including 55 upregulated and 188 downregulated DEGs, were found in CCa patients with LNM versus those without LNM. Among these, FABP4 was found to be closely associated with poor OS. Multivariate analysis uncovered that FABP4 was an independent risk factor for OS and LNM in patients with CCa. The immunohistochemical results verified dramatically increased FABP4 expression in CCa tissues compared to normal cervical epithelia and its association with poor OS and LNM. In vitro, The proliferation, migration and invasion of cervical cancer cells were significantly inhibited after knocking down of FABP4, which was accompanied by elevated expression of E-cadherin and downregulated expression of N-cadherin, Vimentin and p-AKT. Conclusions FABP4 might be a promising biomarker of LNM and survival in patients with early-stage CCa and therefore could significantly contribute to the development of personalized prognosis prediction and therapy optimization.

FABP7 inhibits proliferation and invasion abilities of cutaneous squamous cell carcinoma cells via the Notch signaling pathway

Overexpression of FABP7 Promotes Cell Growth and Predicts Poor Prognosis of Clear Cell Renal Cell Carcinoma1contributed Equally.

Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting -Catenin Degradation

Metastatic Tumor Cell-Specific FABP7 Promotes NSCLC Metastasis via Inhibiting β-Catenin Degradation

FABP5 regulates the proliferation of clear cell renal cell carcinoma cells via the PI3K/AKT signaling pathway

FABP5 Promotes Lymph Node Metastasis in Cervical Cancer by Reprogramming Fatty Acid Metabolism.

Fbxw7 Regulates Hepatocellular Carcinoma Migration and Invasion Via Notch1 Signaling Pathway.

IGFBP7 Plays a Potential Tumor Suppressor Role Against Colorectal Carcinogenesis with Its Expression Associated with DNA Hypomethylation of Exon 1

FABP7 is a potential biomarker to predict response to neoadjuvant chemotherapy for breast cancer

IGFBP7 is Associated to Prognosis and Could Suppress Cell Survival in Cholangiocarcinoma

FABP4 is an independent risk factor for lymph node metastasis and poor prognosis in patients with cervical cancer

Fatty Acid Binding Protein 6 Inhibition Decreases Cell Cycle Progression, Migration and Autophagy in Bladder Cancers

FGFBP1, a Downstream Target of the FBW7/c-Myc Axis, Promotes Cell Proliferation and Migration in Pancreatic Cancer.

FABP5 correlates with poor prognosis and promotes tumor cell growth and metastasis in cervical cancer

FBXW7 promotes autophagy and inhibits proliferation of oral squamous cell carcinoma

MicroRNA‑7 suppresses human colon cancer invasion and proliferation by targeting the expression of focal adhesion kinase.

Downregulation of FABP5 Suppresses the Proliferation and Induces the Apoptosis of Gastric Cancer Cells Through the Hippo Signaling Pathway.

Ligand Bound Fatty Acid Binding Protein 7 (FABP7) Drives Melanoma Cell Proliferation Via Modulation of Wnt/β-Catenin Signaling

FGF6 inhibits oral squamous cell carcinoma progression by regulating PI3K/AKT and MAPK pathways

FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis

Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.